You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 3, March 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Primary Sarcomas of the Major Salivary Glands

Mario A. Luna, MD; M. Eugenia Tortoledo, MD; Nelson G. Ordóñez, MD; Robert A. Frankenthaler, MD; John G. Batsakis, MD

Arch Otolaryngol Head Neck Surg. 1991;117(3):302-306.


Abstract

• Sarcomas arising in the major salivary glands are rare. This article presents the clinicopathologic features of 11 patients with primary sarcomas of the parotid gland (eight men and three women aged 7 to 75 years; mean age, 42 years). The 11 sarcomas were histologically typified as follows: three malignant fibrous histiocytomas and two each of neurosarcomas, rhabdomyosarcomas, fibrosarcomas, and osteosarcomas. Four patients experienced disease recurrences, and seven patients developed metastases. Seven patients died of their sarcomas, with a mean survival time of 30 months. Four patients were alive from 5 to 12 years (one each with angiomatoid malignant fibrous histiocytoma, embryonal rhabdomyosarcoma, fibrosarcoma, and neurosarcoma). Prognosis correlated with size of the neoplasm, type of sarcoma, and histologic grade. In this respect, salivary gland sarcomas behaved in identical fashion to their soft-tissue counterparts.

(Arch Otolaryngol Head Neck Surg. 1991;117:302-306)



Author Affiliations

From the Departments of Pathology (Drs Luna, Tortoledo, Ordóñez, and Batsakis) and Head and Neck Surgery (Dr Frankenthaler), The University of Texas M. D. Anderson Cancer Center, Houston.


Footnotes

Accepted for publication October 15, 1990.

Reprint requests to Department of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 85, Houston, TX 77030 (Dr Luna).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nodal Metastasis in Major Salivary Gland Cancer: Predictive Factors and Effects on Survival
Bhattacharyya and Fried
Arch Otolaryngol Head Neck Surg 2002;128:904-908.
ABSTRACT | FULL TEXT  

Malignant Fibrous Histiocytoma (Giant Cell Type) Associated with a Malignant Mixed Tumor in the Salivary Gland of a Dog
Perez-Martinez et al.
Vet Pathol 2000;37:350-353.
ABSTRACT | FULL TEXT  

Synovial Sarcoma of the Parotid Gland Region: A Case Report and Review of the Literature
Yu et al.
INT J SURG PATHOL 1997;4:239-243.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.